750(top 15%)
articles
35K(top 9%)
citations
281(top 10%)
★★ articles
13(top 8%)
★★★ articles
3.6(top 8%)
Avg IF
100(top 7%)
H-Index
153(top 8%)
G-Index
151
journals

Most Cited Articles of Wessex Regional Genetics Laboratory in 2013

TitleJournalYearCitations
Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomasNature Genetics2013686
Mutations and prognosis in primary myelofibrosisLeukemia2013520
Minimal residual disease assessed by multiparameter flow cytometry in multiple myeloma: impact on outcome in the Medical Research Council Myeloma IX StudyJournal of Clinical Oncology2013313
Recurrent SETBP1 mutations in atypical chronic myeloid leukemiaNature Genetics2013272
Comprehensive mutational profiling in advanced systemic mastocytosisBlood2013183
The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trialBlood2013167
Long-term follow-up of MRC Myeloma IX trial: Survival outcomes with bisphosphonate and thalidomide treatmentClinical Cancer Research2013116
The clinical utility of microarray technologies applied to prenatal cytogenetics in the presence of a normal conventional karyotype: a review of the literaturePrenatal Diagnosis2013109
The clinical implementation of non-invasive prenatal diagnosis for single-gene disorders: challenges and progress madePrenatal Diagnosis2013101
Characterization of IGH locus breakpoints in multiple myeloma indicates a subset of translocations appear to occur in pregerminal center B cellsBlood2013101
Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) studyLeukemia201378
Ponatinib as targeted therapy for FGFR1 fusions associated with the 8p11 myeloproliferative syndromeHaematologica201360
Transient neonatal diabetes, ZFP57, and hypomethylation of multiple imprinted loci: a detailed follow-upDiabetes Care201348
Long-term follow-up of treatment with imatinib in eosinophilia-associated myeloid/lymphoid neoplasms with PDGFR rearrangements in blast phaseLeukemia201346
Inherited predisposition to myeloproliferative neoplasmsTherapeutic Advances in Hematology201340
Aberrant DNA methylation profile of chronic and transformed classic Philadelphia-negative myeloproliferative neoplasmsHaematologica201337
8p23.1 duplication syndrome; common, confirmed, and novel features in six further patientsAmerican Journal of Medical Genetics, Part A201332
A TC classification-based predictor for multiple myeloma using multiplexed real-time quantitative PCRLeukemia201331
Next generation diagnostics in inherited arrhythmia syndromes : a comparison of two approachesJournal of Cardiovascular Translational Research201328
16p11.2-p12.2 duplication syndrome; a genomic condition differentiated from euchromatic variation of 16p11.2European Journal of Human Genetics201328
Detailed clinical and molecular study of 20 females with Xq deletions with special reference to menstruation and fertilityEuropean Journal of Medical Genetics201326
Ruxolitinib as potential targeted therapy for patients with JAK2 rearrangementsHaematologica201326
Diagnostic screening identifies a wide range of mutations involving the SHOX gene, including a common 47.5 kb deletion 160 kb downstream with a variable phenotypic effectAmerican Journal of Medical Genetics, Part A201325
A comparison of methods for EGFR mutation testing in non-small cell lung cancerDiagnostic Molecular Pathology201322
JAK2V617F allele burden, JAK2 46/1 haplotype and clinical features of Chinese with myeloproliferative neoplasmsLeukemia201320